Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 110501-110550 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT03904771
Food for Mind - Intervention in the Treatment of Depression
NA
Recruiting
144 participants
Started: Nov 27, 2017 · Completed: Dec 31, 2025
1 condition
3 sponsors
1 location
NCT03376867
Reference Values and Clinical Screening Test of Diffuse Noxious Inhibitory Controls (DNIC)
N/A
Active, not recruiting
468 participants
Started: Nov 27, 2017 · Completed: Dec 30, 2024
1 condition
4 sponsors
1 location
NCT03797482
A Prospective Evaluation of the Peri-operative Hypoxia in Breast Cancer
N/A
Recruiting
500 participants
Started: Nov 27, 2017 · Completed: Nov 30, 2025
1 condition
1 sponsor
1 location
NCT03179943
Atezolizumab + Guadecitabine in Patients With Checkpoint Inhibitor Refractory or Resistant Urothelial Carcinoma
PHASE2
Active, not recruiting
21 participants
Started: Nov 27, 2017 · Completed: Jul 31, 2022
1 condition
3 sponsors
3 locations
NCT03256981
Stereotactic Body Radiotherapy for the Treatment of OPD
PHASE2/PHASE3
Active, not recruiting
113 participants
Started: Nov 27, 2017 · Completed: Jun 30, 2025
1 condition
1 sponsor
29 locations
NCT03024164
Stroke Registration of Young Adults in China
N/A
Recruiting
3,000 participants
Started: Nov 26, 2017 · Completed: Jul 31, 2025
1 condition
22 sponsors
1 location
NCT05067712
The Effect of Surgical Technique on PDC
NA
Active, not recruiting
88 participants
Started: Nov 25, 2017 · Completed: Dec 31, 2024
1 condition
2 sponsors
2 locations
NCT03345173
Facilitating Rapid Naltrexone Initiation
PHASE3
Active, not recruiting
100 participants
Started: Nov 25, 2017 · Completed: Oct 31, 2024
1 condition
2 sponsors
1 location
NCT03614689
Assessment of the Minimal Residual Disease in Ovarian Cancer From Circulating Tumor DNA and Immune Repertoire
N/A
Active, not recruiting
104 participants
Started: Nov 25, 2017 · Completed: Dec 31, 2024
1 condition
2 sponsors
6 locations
NCT03332797
A Study of GDC-9545 Alone or in Combination With Palbociclib and/or Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer
PHASE1
Active, not recruiting
181 participants
Started: Nov 24, 2017 · Completed: Jul 31, 2026
1 condition
1 sponsor
23 locations
NCT03360591
Functional Assessment in TAVI: FAITAVI
NA
Active, not recruiting
320 participants
Started: Nov 24, 2017 · Completed: Jun 30, 2025
2 conditions
1 sponsor
1 location
NCT03236428
Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma
PHASE2
Active, not recruiting
42 participants
Started: Nov 24, 2017 · Completed: Oct 4, 2026
2 conditions
5 sponsors
6 locations
NCT04095637
RCT: Mako Medial Unicondylar Knee Arthroplasty vs Oxford Unicondylar Knee Arthroplasty
NA
Recruiting
140 participants
Started: Nov 24, 2017 · Completed: Jan 1, 2026
3 conditions
2 sponsors
1 location
NCT03141671
Randomized Phase II Study of Salvage XRT + ADT +/- Abiraterone and Apalutamide for Rising PSA After RP (FORMULA-509)
PHASE2
Active, not recruiting
345 participants
Started: Nov 24, 2017 · Completed: Dec 31, 2025
1 condition
2 sponsors
8 locations
NCT02901184
Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction
PHASE3
Recruiting
2,000 participants
Started: Nov 23, 2017 · Completed: Dec 31, 2026
1 condition
4 sponsors
78 locations
NCT03375983
Plasmodium Immunotherapy for Advanced Cancers
PHASE1/PHASE2
Recruiting
20 participants
Started: Nov 23, 2017 · Completed: Jul 31, 2026
1 condition
1 sponsor
1 location
NCT03322072
Calypso Guided High Precision Stereotactic Ablative Radiosurgery for Lung TUmours Using Real-Time Tumour Tracking & Respiratory Gating
NA
Active, not recruiting
28 participants
Started: Nov 23, 2017 · Completed: Jan 14, 2025
5 conditions
2 sponsors
2 locations
NCT03957733
Phase II/III Study to Assess the Efficacy of Neoadjuvant Consolidation Chemotherapy in Rectal Cancer Patients.
PHASE2/PHASE3
Recruiting
338 participants
Started: Nov 23, 2017 · Completed: Nov 23, 2025
1 condition
4 sponsors
1 location
NCT03189485
Tau PET Imaging in the NACC Study Cohort
N/A
Recruiting
200 participants
Started: Nov 22, 2017 · Completed: May 31, 2026
2 conditions
3 sponsors
1 location
NCT03217396
Biomarkers of Synaptic Damage in Multiple Sclerosis
N/A
Recruiting
300 participants
Started: Nov 22, 2017 · Completed: Sep 30, 2027
4 conditions
2 sponsors
1 location
NCT03030261
Elotuzumab, Pomalidomide, & Dexamethasone (Elo-Pom-Dex) With Second Autologous Stem Cell Transplantation for Relapsed Multiple Myeloma
PHASE2
Active, not recruiting
25 participants
Started: Nov 22, 2017 · Completed: Sep 26, 2027
1 condition
3 sponsors
3 locations
NCT03093909
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
PHASE1
Recruiting
44 participants
Started: Nov 22, 2017 · Completed: Nov 30, 2025
10 conditions
3 sponsors
1 location
NCT03349385
Registry of Secondary Revascularization
N/A
Active, not recruiting
869 participants
Started: Nov 22, 2017 · Completed: Dec 15, 2025
5 conditions
3 sponsors
1 location
NCT03228472
Noninvasive Brain Stimulation Training
NA
Recruiting
100 participants
Started: Nov 22, 2017 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03356028
Pedopsychiatric and Multidisciplinary Research Devoted to Children Exposed to the Attack in Nice on July 14, 2016
NA
Active, not recruiting
728 participants
Started: Nov 21, 2017 · Completed: Dec 31, 2044
2 conditions
1 sponsor
1 location
NCT03317158
Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the Bladder
PHASE1/PHASE2
Recruiting
55 participants
Started: Nov 21, 2017 · Completed: Dec 31, 2026
2 conditions
3 sponsors
12 locations
NCT03321045
Positron Emission Tomography (PET) Imaging with Zirconium-89 (89Zr)-Trastuzumab for Prediction of HER2 Targeted Therapy Effectiveness
EARLY_PHASE1
Recruiting
10 participants
Started: Nov 21, 2017 · Completed: Oct 31, 2027
1 condition
1 sponsor
1 location
NCT03682029
Epigenetics, Vitamin C, and Abnormal Blood Cell Formation - Vitamin C in Patients With Low-Risk Myeloid Malignancies
NA
Active, not recruiting
109 participants
Started: Nov 21, 2017 · Completed: Sep 27, 2025
3 conditions
8 sponsors
5 locations
NCT03298802
Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide
PHASE3
Recruiting
612 participants
Started: Nov 21, 2017 · Completed: Aug 30, 2024
6 conditions
1 sponsor
2 locations
NCT03310879
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
PHASE2
Recruiting
38 participants
Started: Nov 21, 2017 · Completed: Sep 30, 2026
1 condition
2 sponsors
1 location
NCT04078412
A Registry for Nontuberculous Mycobacterial Pulmonary Disease
N/A
Enrolling by invitation
114 participants
Started: Nov 21, 2017 · Completed: Nov 30, 2027
1 condition
1 sponsor
1 location
NCT03096366
Does Blood Flow Restriction Training Improve Quadriceps Function After Arthroscopic Knee Surgery?
NA
Recruiting
150 participants
Started: Nov 21, 2017 · Completed: Dec 31, 2022
2 conditions
2 sponsors
1 location
NCT03352765
A Phase I Study of Bendamustine and Melphalan Conditioning and Autologous Stem Cell Transplantation for Treatment of Multiple Myeloma and Relapsed/Refractory B-cell Lymphoma in Elderly Patients
PHASE1
Active, not recruiting
28 participants
Started: Nov 20, 2017 · Completed: Nov 30, 2025
1 condition
1 sponsor
1 location
NCT03781115
Proposal To Develop A Rapid And Cost-Effective Diagnostic Test For Schizophrenia
PHASE1
Recruiting
24 participants
Started: Nov 20, 2017 · Completed: Feb 10, 2026
1 condition
2 sponsors
1 location
NCT03344848
Early Feasibility Study of the Orion Visual Cortical Prosthesis System
NA
Active, not recruiting
6 participants
Started: Nov 20, 2017 · Completed: Mar 31, 2025
1 condition
2 sponsors
2 locations
NCT03261206
Stopping Aminosalicylate Therapy in Inactive Crohn's Disease
PHASE4
Active, not recruiting
334 participants
Started: Nov 20, 2017 · Completed: Jun 30, 2026
2 conditions
2 sponsors
46 locations
NCT03334006
Prospective, Randomized Trial of Personalized Medicine With Pentaglobin® After Surgical Infectious Source Control in Patients With Peritonitis
PHASE2
Recruiting
200 participants
Started: Nov 20, 2017 · Completed: Mar 31, 2028
3 conditions
2 sponsors
20 locations
NCT03352258
Effect of Low Dose Radiotherapy on Brain Amyloidosis in the Treatment of Alzheimer's Disease
NA
Active, not recruiting
20 participants
Started: Nov 17, 2017 · Completed: Dec 30, 2027
1 condition
1 sponsor
1 location
NCT03277547
Kidney Function in Sickle Cell Anemia
N/A
Active, not recruiting
300 participants
Started: Nov 17, 2017 · Completed: Dec 1, 2025
2 conditions
3 sponsors
3 locations
NCT03625921
Transfemoral Powered Foot and Physical Therapy Study
NA
Active, not recruiting
20 participants
Started: Nov 17, 2017 · Completed: Jan 14, 2026
2 conditions
2 sponsors
1 location
NCT05056207
PREVENT: PeRomEter Visualization to ENd Treatment-related Lymphedema
NA
Active, not recruiting
260 participants
Started: Nov 17, 2017 · Completed: Nov 17, 2026
1 condition
1 sponsor
1 location
NCT02724579
Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma
PHASE2
Active, not recruiting
45 participants
Started: Nov 17, 2017 · Completed: Jun 30, 2027
1 condition
2 sponsors
195 locations
NCT04780009
Loupe-Based Intraoperative Fluorescence Imaging
N/A
Recruiting
30 participants
Started: Nov 17, 2017 · Completed: Jun 30, 2026
2 conditions
4 sponsors
1 location
NCT03227042
A Prospective Natural History Study of Mucopolysaccharidosis Type IIIB (MPS IIIB)
N/A
Active, not recruiting
44 participants
Started: Nov 16, 2017 · Completed: Dec 31, 2025
1 condition
1 sponsor
9 locations
NCT03274492
A Study Comparing the Efficacy and Safety of Polatuzumab Vedotin With Rituximab-Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Diffuse Large B-Cell Lymphoma
PHASE3
Active, not recruiting
1,000 participants
Started: Nov 16, 2017 · Completed: Jul 5, 2026
1 condition
1 sponsor
216 locations
NCT03201848
The Efficacy and Safety of Huaiqihuang Granule in Children With Chronic Primary Immune Thrombocytopenia
PHASE4
Active, not recruiting
216 participants
Started: Nov 16, 2017 · Completed: Jun 30, 2024
1 condition
2 sponsors
14 locations
NCT03088059
Biomarker-based Study in R/M SCCHN
PHASE2
Active, not recruiting
340 participants
Started: Nov 16, 2017 · Completed: Dec 31, 2025
1 condition
1 sponsor
36 locations
NCT03351348
Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control
PHASE3
Recruiting
165 participants
Started: Nov 16, 2017 · Completed: Nov 30, 2026
1 condition
1 sponsor
7 locations
NCT03359954
Radiation Therapy Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Breast Cancer
PHASE2
Active, not recruiting
25 participants
Started: Nov 16, 2017 · Completed: Oct 31, 2027
4 conditions
2 sponsors
1 location
NCT03489239
Entecavir to TAF Switch
PHASE3
Active, not recruiting
27 participants
Started: Nov 16, 2017 · Completed: Sep 16, 2020
1 condition
2 sponsors
1 location
Previous
1
More pages
2208
2209
2210
2211
2212
2213
2214
More pages
2369
Next